Tag: Paul-Le-Floch

1 article

Industry News

Axoft wants its brain probe to tell doctors whether a patient is conscious

Cambridge, Massachusetts brain-computer interface company Axoft reported early human data from its ultra-soft Fleuron probes on 19 November 2026, from patients at Mass General Brigham and The Panama Clinic. Its first clinical target is disorders of consciousness: measuring consciousness directly in patients with severe brain injury who cannot respond. The results were presented at three conferences and have not yet appeared in a peer-reviewed journal.

Nov 20